OmniGuide — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

OmniGuide is a commercial-stage medical device company specializing in advanced energy-based surgical systems, primarily laser platforms and fibers. Its core technology revolves around Thulium and CO2 laser systems, integrated with proprietary features like KühleDust and StopRÖK software, targeting urology, gynecology, ENT, neurology, and cardiothoracic surgery. The company emphasizes US manufacturing and leverages a significant clinical evidence base, particularly through its RevoLix therapy platform, to compete against established Holmium YAG and Thulium Fiber Laser systems. OmniGuide appears to be a private, revenue-generating entity focused on penetrating the surgical laser market with differentiated performance claims.

UrologyGynecologyOtolaryngology (ENT)NeurologyCardiothoracic Surgery

Technology Platform

Integrated surgical laser ecosystems based on Thulium and CO2 energy sources. The platform combines laser engines, proprietary software (e.g., StopRÖK for kinetic control), thermal management tech (KühleDust), and specialized laser fibers designed for high power, flexibility, and precision in minimally invasive and robotic surgery.

Opportunities

The large and growing market for minimally invasive surgical lasers, particularly in urology for BPH and stones, presents a major opportunity.

OmniGuide's performance claims (faster dusting, no retropulsion) directly address limitations of current standards, offering a compelling value proposition.

Expansion into robotic surgery and other specialties (ENT, neurosurgery) provides additional growth vectors.

Risk Factors

The company faces intense competition from large, established medtech players with greater sales and marketing resources.

Its heavy reliance on a partnership with LISA Laser for core technology creates supply chain and strategic dependency risks.

Driving clinical adoption away from the entrenched Holmium YAG standard requires significant investment and evidence.

Competitive Landscape

OmniGuide competes in the surgical laser market against dominant players like Boston Scientific (Lumenis), Olympus, and Stryker, who offer Holmium YAG and other laser systems. It also competes with newer Thulium Fiber Laser (TFL) companies. Its strategy is to differentiate on specific technical performance metrics (power, speed, retropulsion control) and system integration.

More companies in United States →